WVE Q3 2020 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+17.8% YoY

Gross Profit

-$25M-719.6% margin

Operating Income

-$34M-997.5% margin

Net Income

-$33M-959.4% margin

EPS (Diluted)

$-0.86

QoQ Revenue Growth

+14.0%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$310M

Total Liabilities

$202M

Stockholders' Equity

$108M

Cash & Equivalents

$216M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+17.8%
Gross Profit	-$25M	-$42M	+40.4%
Operating Income	-$34M	-$54M	+36.5%
Net Income	-$33M	-$51M	+34.7%